Skip to page content

Objective Analysis. Effective Solutions.

Site-wide navigation

About RAND
RAND Campaign
Press Room
Careers

Research
Research Areas
Trending Topics
All Topics Browse Reports
Research Divisions
Research Departments
Latest Insights
Reports
How to Support Victims of Elder Mistreatment

Climate Change Affects Health and Will Increase Drug Demand
Commentary and Articles
Why Cringe-Worthy School Start Times Are Bad for Kids

Rest Up for Race Day: Sleep Tips for Chicago Marathoners
Multimedia
The Math Equity Equation

The Policy Currents Podcast
Policy Experts
All Experts

Spotlight
- Wendy M. Troxel @wendytroxel
  
  Commentary:
  
  Why Cringe-Worthy School Start Times Are Bad for Kids
- Raphael S. Cohen
  
  Commentary:
  
  Iran's Terrible, Horrible, Very Bad Year
By Research Area
Capabilities
Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms.
Capabilities Overview

RAND Solutions

Who We Work For

Public Sector

Philanthropic Sector

Private Sector

Work with Us

Explore Business Contacts

About RAND Research

Disciplinary Expertise

Quality Standards

Methodological Innovation
Featured Solutions
Getting to Know Military Caregivers and Their Needs

Managing Escalation in Crisis and War

Assessing and Articulating the Wider Benefits of Research

Improving Access to Early Childhood Education
Graduate School
The Pardee RAND Graduate School (PardeeRAND.edu) is home to the only Ph.D. and M.Phil. programs offered at an independent public policy research organization—the RAND Corporation.
Featured Video: Campus Tour

Student Life at Pardee RAND
Student Spotlight
- Anujin Nergui
  
  M.Phil. Student, Pardee RAND Graduate School, and Assistant Policy Researcher, RAND
- Amal Altwaijri
  
  Ph.D. Candidate, Pardee RAND Graduate School, and Assistant Policy Researcher, RAND
About

中文(简体)
العربية
Cart

Toggle Search

Site-wide Search

RAND
Topics
>Pharmaceutical Drugs

Pharmaceutical Drugs

Pharmaceutical Drugs

Although pharmaceutical drugs on the whole greatly improve patient outcomes and quality of life when used as prescribed, they are not without their complications. RAND research on pharmaceuticals examines their safety and effectiveness, relevant health economics issues, prescription drug abuse, challenges related to access and adherence, and pharmaceutical regulatory policy.

Related Topics

Antibiotics
Biotechnology
Electronic Pharmaceutical Prescriptions
Health, Health Care, and Aging
Prescription Drug Benefits
Prescription Drug Misuse

Report

Comparing International Prescription Drug Prices

Feb 1, 2024
Commentary

Preparing for the Potential Rollout of New Alzheimer's Drugs: Towards a Policy, Research, and Innovation Agenda

Jan 30, 2024

Explore RAND’s Work on this Topic

Skip to results

Search by keyword

Content Type
- Journal Article (290)
- Report (54)
- Commentary (52)
- News Release (48)
- Research Brief (21)
- Project (14)
- Dissertation (10)
- Multimedia (9)
- Content (6)
- Brochure (5)
- Tool (5)
- Testimony (4)
- Periodical (3)
- Commercial Book (1)
- Event (1)
- Infographic (1)
- Media Advisory (1)
- Q&A (1)
- Visualization (1)
Subtopic
- Prescription Drug Benefits (109)
- Prescription Drug Misuse (91)
- Antibiotics (43)
- Medicare Part D (43)
- Electronic Pharmaceutical Prescriptions (31)
Region
Most relevant regions
- Americas (77)
- North America (76)
- United States (75)
- Europe (18)
- Southwestern States (14)
- California (11)
- Pacific States (11)
- United Kingdom (11)
- Atlantic States (5)
- China (4)
Date
- Last 30 days
- Last 90 days
- Last year
- Last two years
to

527 Results

number of items to display at a time

Error

Report

Aug 5, 2021

RAND Technical Expert Panel Medicare Advantage (MA) and Part D Contract Star Ratings, May 5, 2021 Meeting

The RAND team gathered input from experts about stratified reporting by Part D low-income subsidy (LIS) and dual eligibility (DE), and disability and assessing social risk factors of Medicare Advantage (MA) and Part D contract beneficiaries.
Journal Article

Jun 30, 2021

Variation in Generic Dispensing Rates in Medicare Part D

Although generic use has increased markedly over time in Part D, substantial variation across plans persists in a number of common therapeutic classes.
Content

Jun 14, 2021

Strategies for Effectively Allocating Opioid Settlement Funds

Opioid settlements with pharmaceutical companies have already occurred, and there are more to come. OPTIC researchers have compiled guiding principles, recommendations, and effectiveness studies to assist those who will be allocating opioid settlement funds.
Journal Article

Jun 10, 2021

Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the U.S.

Drawing on national retail pharmacy data, researchers identified and categorized clinicians who prescribed buprenorphine for OUD at least once between January 2017 and December 2018.
News Release

Jun 1, 2021

Most Prescriptions for Opioid Addiction Medication Buprenorphine Are Written by a Small Number of Providers

Most prescriptions for the drug buprenorphine, used to treat opioid use disorder, are written by a small number of the health care providers.
Journal Article

May 26, 2021

Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes from a Review of State Laws

Buprenorphine is a gold standard treatment for opioid use disorder. Some states have passed laws regulating office-based buprenorphine treatment, with requirements beyond those required in federal law. This study identified themes in state laws.
Research Brief

Apr 28, 2021

2018 Health Related Behaviors Survey: Substance Use Among the Reserve Component

The 2018 Health Related Behaviors Survey sought information on the health and health behaviors of service members. This brief reviews results for substance use among reserve component members, particularly use of alcohol, tobacco, and medication.
Research Brief

Apr 28, 2021

2018 Health Related Behaviors Survey: Substance Use Among the Active Component

The 2018 Health Related Behaviors Survey sought information on the health and health behaviors of service members. This brief reviews results for substance use among active component members, particularly use of alcohol, tobacco, and medication.
Journal Article

Apr 27, 2021

Growing Racial/Ethnic Disparities in Buprenorphine Distribution in the United States, 2007–2017

We find ecological evidence consistent with racial/ethnic disparities in buprenorphine distribution. Our finding that initiatives to increase the number of waivered prescribers are insufficient to achieve equitable buprenorphine access.
Research Brief

Apr 14, 2021

U.S. Prescription Drug Prices Are 2.5 Times Those in Other OECD Countries

RAND researchers used 2018 prescription drug volume and price data to compare U.S. drug prices with those in 32 other nations, both overall and for specific categories of drugs, such as brand-name and generic medications.
Journal Article

Apr 13, 2021

Prescribers and Naloxone Pharmacy Claims

Commentary on an article by Truong, Patil, and Rich, on the benefits and dangers of naloxone prescriptions.
Journal Article

Apr 9, 2021

Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System

Older adults are particularly vulnerable to complications from proton pump inhibitor drugs. We sought to characterize the prevalence of potentially low-value PPI prescriptions among older adults to inform a quality improvement intervention.

Previous
1
...
6
7
8
9
10
11
...
44
Next

Oops! An unexpected error has occurred.

Please try again. If you see this message repeatedly, there may be a problem with site functionality at this time. Thanks for your patience while we work to resolve the problem.

Subscribe to the Policy Currents newsletter

Email

View all newsletters

About

RAND is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest.

RAND History
Diversity, Equity, and Inclusion
Leadership
Research Integrity
Career Opportunities

Connect

Contact Us
Locations

I am interested in

Jobs at RAND
Media Resources
Congressional Resources
Doing Business with RAND
Supporting RAND
Educational Opportunities
Alumni Association

Follow

RAND on LinkedIn
RAND on Twitter
RAND on Facebook
RAND on YouTube
RAND on Instagram
Policy Currents Podcast

Stay Informed

Subscribe to the Policy Currents newsletter for RAND insights on the issues that matter most.

Stay Informed

Policy Currents newsletter

Get updates from RAND delivered straight to your inbox.

Email

View all email newsletters

Resources

Multimedia
Latest Reports
Browse by Author
RAND Classics
Databases and Tools

Site Information

Site Map
PRIVACY POLICY
Support Policy
Feedback
Help

1776 Main Street
Santa Monica, California 90401-3208

RAND® is a registered trademark. © 2024 RAND Corporation. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.